Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Insulin receptor engineering in regulatory T cells for enhanced anti-diabetes function

EF 2022-23

Résumé
Type 1 diabetes (T1D) is a life-threatening disease caused by autoimmune destruction of the insulin-secreting beta cells of the pancreas. In healthy people, immune cells called regulatory T cells (Tregs) regulate immune responses and prevent autoimmune conditions, but this protection is lost in T1D. New therapies using Tregs to treat T1D are being designed to restore immune balance. The Tregs are engineered in the lab to improve their ability to fight autoimmune attack, then infused into T1D patients. However, animal studies and our preliminary results in human Tregs show that insulin exposure impairs typical Treg function, implying that in the pancreas, the presence of insulin itself may be a problem for Tregs. Thus, my research will focus on understanding how insulin affects Treg function and testing a genetic engineering strategy that could allow Tregs to function better in insulin-rich environments such as the pancreas. Specifically, we plan to replace the insulin receptor, which allows Tregs to sense insulin, with an alternative receptor that will sense insulin but deliver a beneficial signal to Tregs that helps their growth and survival. By converting the detrimental effects of insulin on Tregs into something that benefits their function, we hope to improve the effectiveness of Treg-based therapies, which hold the potential to cure T1D.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486417
Name
HALVORSON TORIN J
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Insulin receptor engineering in regulatory T cells for enhanced anti-diabetes function
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adoptive Cell Therapy; Chimeric Antigen Receptor; Crispr; Insulin Signalling; Regulatory T Cells; Type 1 Diabetes
Abstract
Type 1 diabetes (T1D) is a life-threatening disease caused by autoimmune destruction of the insulin-secreting beta cells of the pancreas. In healthy people, immune cells called regulatory T cells (Tregs) regulate immune responses and prevent autoimmune conditions, but this protection is lost in T1D. New therapies using Tregs to treat T1D are being designed to restore immune balance. The Tregs are engineered in the lab to improve their ability to fight autoimmune attack, then infused into T1D patients. However, animal studies and our preliminary results in human Tregs show that insulin exposure impairs typical Treg function, implying that in the pancreas, the presence of insulin itself may be a problem for Tregs. Thus, my research will focus on understanding how insulin affects Treg function and testing a genetic engineering strategy that could allow Tregs to function better in insulin-rich environments such as the pancreas. Specifically, we plan to replace the insulin receptor, which allows Tregs to sense insulin, with an alternative receptor that will sense insulin but deliver a beneficial signal to Tregs that helps their growth and survival. By converting the detrimental effects of insulin on Tregs into something that benefits their function, we hope to improve the effectiveness of Treg-based therapies, which hold the potential to cure T1D.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
HALVORSON, TORIN J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~